Previous studies have found that irisin reduces atherosclerosis in apolipoprotein E-deficient mice by inhibiting ox-LDL (oxidized low-density lipoprotein)-induced cellular inflammation and apoptosis [74]. The gene discussed is FNDC5; the disease is atherosclerosis.